These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30553625)

  • 21. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
    Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides.
    Métayer B; Mingot A; Vullo D; Supuran CT; Thibaudeau S
    Chem Commun (Camb); 2013 Jul; 49(54):6015-7. PubMed ID: 23503420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors.
    Chiaramonte N; Bua S; Angeli A; Ferraroni M; Picchioni I; Bartolucci G; Braconi L; Dei S; Teodori E; Supuran CT; Romanelli MN
    Bioorg Chem; 2019 Oct; 91():103130. PubMed ID: 31374520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
    Knaus EE; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5892-6. PubMed ID: 21852133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
    Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII.
    Čapkauskaitė E; Baranauskienė L; Golovenko D; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7357-64. PubMed ID: 20926301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic Thermodynamics and Structure Correlation of Benzenesulfonamides with a Pyrimidine Moiety Binding to Carbonic Anhydrases I, II, VII, XII, and XIII.
    Kišonaitė M; Zubrienė A; Capkauskaitė E; Smirnov A; Smirnovienė J; Kairys V; Michailovienė V; Manakova E; Gražulis S; Matulis D
    PLoS One; 2014; 9(12):e114106. PubMed ID: 25493428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
    Güzel-Akdemir Ö; Akdemir A; Isik S; Vullo D; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1386-91. PubMed ID: 23352754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII.
    Bozdag M; Alafeefy AM; Altamimi AM; Carta F; Supuran CT; Vullo D
    Bioorg Med Chem; 2017 May; 25(10):2782-2788. PubMed ID: 28389112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design.
    Linkuvienė V; Zubrienė A; Manakova E; Petrauskas V; Baranauskienė L; Zakšauskas A; Smirnov A; Gražulis S; Ladbury JE; Matulis D
    Q Rev Biophys; 2018 Jan; 51():e10. PubMed ID: 30912486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of novel acridine and bis acridine sulfonamides with effective inhibitory activity against the cytosolic carbonic anhydrase isoforms II and VII.
    Ulus R; Yeşildağ I; Tanç M; Bülbül M; Kaya M; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(18):5799-805. PubMed ID: 23910989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrinsic thermodynamics of inhibitor binding to human carbonic anhydrase IX.
    Linkuvienė V; Matulienė J; Juozapaitienė V; Michailovienė V; Jachno J; Matulis D
    Biochim Biophys Acta; 2016 Apr; 1860(4):708-18. PubMed ID: 26794023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
    Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
    Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonic anhydrase inhibitors: benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms IX and XII.
    Alafeefy AM; Isik S; Abdel-Aziz HA; Ashour AE; Vullo D; Al-Jaber NA; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1396-403. PubMed ID: 23290254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety.
    Buemi MR; Di Fiore A; De Luca L; Angeli A; Mancuso F; Ferro S; Monti SM; Buonanno M; Russo E; De Sarro G; De Simone G; Supuran CT; Gitto R
    Eur J Med Chem; 2019 Feb; 163():443-452. PubMed ID: 30530195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
    D'Ambrosio K; Vitale RM; Dogné JM; Masereel B; Innocenti A; Scozzafava A; De Simone G; Supuran CT
    J Med Chem; 2008 Jun; 51(11):3230-7. PubMed ID: 18481843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.